ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 1450

Regulatory Mechanisms of Mesenchymal Stem Cell Transplantation on Systemic Osteoporosis in Collagen-Induced Arthritis Mice

Chang Liu, Huayong Zhang, Xiaojun Tang, Ruihai Feng, Genhong Yao, Weiwei Chen, Wenchao Li and Lingyun Sun, Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Arthritis, mesenchymal stem cells and osteoporosis

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 14, 2016

Session Title: Rheumatoid Arthritis – Animal Models - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  To investigate the effects of umbilical cord-mesenchymal stem cell (UC-MSC) transplantation on joint damage and systemic osteoporosis in collagen induced arthritis (CIA) mice.

Methods: DBA/1 male mice were induced to CIA models by injecting type II Collagen (CII). Then CIA mice were divided into four groups, including CIA control group, UC-MSC transplantation group, anti-tumor necrosis factor alpha (anti-TNFα) treatment group and zoledronic acid (ZA) treatment group. The CIA mice were treated for 8 weeks. Arthritis score of CIA mice were evaluated every 3 days. Micro computed tomography (micro-CT) was used to analyze the bone morphology parameters. Bone marrow mesenchymal stem cells (BMMSCs) were isolated and cultured in the osteogenic medium. Osteogenic differentiation was determined by alkaline phosphatase (ALP) staining and ALP activity on day 7. The expression of the osteogenic markers ALP, Osterix and type I collagen (COL-I) were analyzed by RT-PCR and western bloton day 7 and day 14 respectively. Moreover, bone marrow monocytes (BMMs) were isolated and induced to osteoclast (OC) in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor-КB ligand. OC differentiation was determined by tartrate-resistant acid phosphatase (TRAP) staining and mRNA levels of nuclear factor of activated T cells (NFAT)2 and osteoprotegerin (OPG).

Results: The arthritis score was significantly reduced in UC-MSC transplantation and anti-TNFα treated CIA group compared with control mice. Micro-CT showed that the BMD, trabecular bone volume/total volume (BV/TV) and trabecular number (Tb.N) of the femur were significantly decreased in CIA mice, compared with that in DBA/1 mice. H&E staining also showed a reduced Tb.N in CIA mice. Whereas these parameters were partially improved in UC-MSCs treated CIA mice compared with control mice. Impaired osteogenic differentiation functions were shown by decreased ALP activity, reduced gene and protein levels of osteogenic marker genes in CIA mice compared with DBA/1 mice. UC-MSCs treatment significantly upregulated the osteogenic differentiation ability in CIA mice. Moreover, TRAP staining and OC counting showed that OC number was increased in CIA mice compared to that in DBA/1 mice. The NFAT2 mRNA levels were elevated in CIA mice compared to that in DBA/1 mice, however the OPG mRNA levels were decreased in CIA mice. UC-MSC treatment downregulated the enhanced OC differentiation in CIA mice.

Conclusion: The present study demonstrated that CIA mice developed osteoporosis. UC-MSCs transplantation not only improved the joint damage significantly but also played a positive role in osteoporosis in CIA mice. The osteogenic differentiation ability of BMMSCs in CIA mice was impaired. The OC differentiation function of BMMs in CIA mice was enhanced. UC-MSCs transplantation could upregulate the osteogenic differentiation and downregulate the OC differentiation in CIA mice. Thus, we provide strong evidence that MSCs ameliorate inflammation-induced systemic bone loss in CIA mice by upregulating osteogenic differentiation and reducing OC differentiation.


Disclosure: C. Liu, None; H. Zhang, None; X. Tang, None; R. Feng, None; G. Yao, None; W. Chen, None; W. Li, None; L. Sun, None.

To cite this abstract in AMA style:

Liu C, Zhang H, Tang X, Feng R, Yao G, Chen W, Li W, Sun L. Regulatory Mechanisms of Mesenchymal Stem Cell Transplantation on Systemic Osteoporosis in Collagen-Induced Arthritis Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/regulatory-mechanisms-of-mesenchymal-stem-cell-transplantation-on-systemic-osteoporosis-in-collagen-induced-arthritis-mice/. Accessed February 25, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/regulatory-mechanisms-of-mesenchymal-stem-cell-transplantation-on-systemic-osteoporosis-in-collagen-induced-arthritis-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.